These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22538668)

  • 1. GFP-expressing influenza A virus for evaluation of the efficacy of antiviral agents.
    Kim JI; Park S; Lee I; Lee S; Shin S; Won Y; Hwang MW; Bae JY; Heo J; Hyun HE; Jun H; Lim SS; Park MS
    J Microbiol; 2012 Apr; 50(2):359-62. PubMed ID: 22538668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of influenza resistance and treatment.
    Weinstock DM; Zuccotti G
    JAMA; 2009 Mar; 301(10):1066-9. PubMed ID: 19255112
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
    Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
    PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
    Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NA proteins of influenza A viruses H1N1/2009, H5N1, and H9N2 show differential effects on infection initiation, virus release, and cell-cell fusion.
    Chen Q; Huang S; Chen J; Zhang S; Chen Z
    PLoS One; 2013; 8(1):e54334. PubMed ID: 23349854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different polymerases of avian influenza viruses on the growth and pathogenicity of A/Puerto Rico/8/1934 (H1N1)-derived reassorted viruses.
    Kim IH; Choi JG; Lee YJ; Kwon HJ; Kim JH
    Vet Microbiol; 2014 Jan; 168(1):41-9. PubMed ID: 24296300
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of antiviral resistance of influenza viruses.
    Monto AS
    Clin Infect Dis; 2009 Feb; 48(4):397-9. PubMed ID: 19586376
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.
    Sleeman K; Mishin VP; Deyde VM; Furuta Y; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2517-24. PubMed ID: 20350949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
    Nacken W; Ehrhardt C; Ludwig S
    Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus.
    Haasbach E; Reiling SJ; Ehrhardt C; Droebner K; Rückle A; Hrincius ER; Leban J; Strobl S; Vitt D; Ludwig S; Planz O
    Antiviral Res; 2013 Sep; 99(3):336-44. PubMed ID: 23811282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro and in vivo effects of a long-acting anti-influenza agent CS-8958 (laninamivir octanoate, Inavir) against pandemic (H1N1) 2009 influenza viruses].
    Kubo S; Kakuta M; Yamashita M
    Jpn J Antibiot; 2010 Oct; 63(5):337-46. PubMed ID: 21268406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H1N1 influenza A virus neuraminidase modulates infectivity in mice.
    Ferraris O; Escuret V; Bouscambert M; Casalegno JS; Jacquot F; Raoul H; Caro V; Valette M; Lina B; Ottmann M
    Antiviral Res; 2012 Mar; 93(3):374-80. PubMed ID: 22321413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Influenza Activity of an Ethyl Acetate Fraction of a
    Kim YS; Li W; Kim JH; Chung HS; Choi JG
    Oxid Med Cell Longev; 2020; 2020():8824934. PubMed ID: 33204399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
    Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
    Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.
    Smee DF; Sidwell RW; Morrison AC; Bailey KW; Baum EZ; Ly L; Wagaman PC
    Antiviral Res; 2001 Dec; 52(3):251-9. PubMed ID: 11675142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dense Granule Protein-7 (GRA-7) of Toxoplasma gondii inhibits viral replication in vitro and in vivo.
    Weeratunga P; Herath TUB; Kim TH; Lee HC; Kim JH; Lee BH; Lee ES; Chathuranga K; Chathuranga WAG; Yang CS; Ma JY; Lee JS
    J Microbiol; 2017 Nov; 55(11):909-917. PubMed ID: 29076073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses.
    Leneva IA; Roberts N; Govorkova EA; Goloubeva OG; Webster RG
    Antiviral Res; 2000 Nov; 48(2):101-15. PubMed ID: 11114412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
    Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.